![](/themes/TruffleTheme/static/img/building-bg/building-bg_ykki6o_c_scale,w_2076.jpg)
Great article about Abivax : what makes it a unique candidate to treat Covid-19
In addition to its exciting results in ulcerative colitis
In addition to its exciting results in ulcerative colitis, Abivax's ABX 464 has shown antiviral, anti-inflammatory and tissue repair properties in COVID-19 clinical trials.